HEALTH

New Zim’s Max logo looks to unify brand’s identity

BY Michael Johnsen

NORTH LIMA, Ohio — Perfecta Products on Monday announced the rebranding of its popular Zim’s product line to Zim’s Max featuring a new logo and package design.
 
“After years of growth, numerous happy customers, and many new additions to the product line, the timing is right to enhance our brand,” said Perfecta Products’ director of marketing and sales Mark Smith. “The new Zim’s Max visually unites our product portfolio around an enhanced brand promise.”
 
The new packaging is a move to better position the Zim’s Max product line under a single identity. It connects all Zim’s Max products, new and old, through a cohesive visual presentation. With the rebrand, Zim’s Max also introduces the selling line, “Nature’s Best, Made Better”; accompanied by a new brand mark. The mark features an interconnected design with an arnica flower representing nature on the left and molecules symbolic of science on the right.
 
Distributed by Perfecta Products, the new Zim’s Max launch is slated to hit the shelves of major retailers nationwide starting this summer. All of the current Zim’s products will be available under the Zim’s Max brand, including Zim’s Max-Freeze. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Study: Pharmacists have measurable impact on improving outcomes

BY Michael Johnsen

EDMONTON, Alberta — Having pharmacists on primary care teams monitoring the treatment of blood pressure in patients with Type 2 diabetes have a significant impact on improved outcomes, according to a study published in the May/June issue of the Journal of the American Pharmacists Association.
 
The main study, which was a randomized control trial, examined blood pressure control in people with Type 2 diabetes as a measurable, clinically important outcome. Results of the main study showed that the addition of pharmacists to primary care teams produced substantial improvements in the health of patients with Type 2 diabetes.
 
Researcher Scot Simpson wanted to delve further and pinpoint what specifically pharmacists did to improve patient health.
 
Patients in the intervention group were counseled directly by two pharmacists, who worked with the patients’ physicians as part of primary care teams at several clinics within Edmonton's Southside Primary Care Network. Control group patients did not see a primary care team pharmacist during the study. At the end of the study, 42% of the intervention group patients had at least one change to their blood pressure drugs compared to 26% of the control group patients.
 
“Based on the data, we found that patients who had a change in blood pressure drugs were twice as likely to have an improvement in their blood pressure compared to those who didn't have a change in blood pressure drugs,” Simpson said. 
 
Simpson's findings support the importance of interprofessional health collaboration in treating patients.
 
“Adding pharmacists to the team to review medications, identify drug-related problems and manage the treatment has a positive effect on blood pressure levels of patients with Type 2 diabetes,” Simpson said. “The pharmacists involved in the study had very collaborative discussions with the physicians about the patients' medications and proposed drug treatment options. … It was from these discussions that the pharmacists were able to suggest alternative medicines or changes in dosage that contributed to lowering the patient's blood pressure.”
 
The study was part of a larger research project published in Diabetes Care in 2011.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Cosmederm launches new ‘calming’ product

BY Michael Johnsen

SAN DIEGO — Cosmederm Bioscience’s TriCalm OTC itch-relief solution was recognized in May by the journal Clinical, Cosmetic and Investigational Dermatology, which published a study finding that Cosmederm’s solution was superior to diphenhydramine 2% and hydrocortisone 1%.

(Click here to read the full Category Review.)

That superior efficacy may translate into a significant sales story going forward. As of April 19, TriCalm 52 week sales totaled 5.2 million on growth of 276.5% across total U.S. multi-outlets, according to IRI.

“The results of this study are a testament to TriCalm’s value as the most effective over-the-counter itch relief treatment,” Sean Edwards, president and CEO of Cosmederm Bioscience, said when announcing the results last month. “They validate our claim that TriCalm is more effective at relieving itch than hydrocortisone 1%, providing fast-acting itch relief without the potential side effects of steroid-based creams.”

Cosmederm Bioscience is looking to bring two new anti-itch solutions to the marketplace for the coming review season, said Justin Brown, Cosmederm Bioscience VP sales. “But we’re in development [of other new products]. We anticipate by the end of the year having 10 really unique formulations, everything ranging from psoriasis products to something as simple as a daily sensitive skin lotion.”

TriCalm has a very aggressive integrated marketing and advertising budget that includes TV, radio, print, social media, internet and doctor initiatives, and is represented by David Biernbaum.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?